🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IMR
Immuneering Corporation
AVG HISTORICAL GAP
+2.39%
MAX GAP RECORD
+24.88%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $IMRX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$IMRX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
+5.69%
|
| May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN) |
-0.78%
|
| Mar 06, 2026 Earnings Release 2026-03-06 (UNDETERMINED) |
+0.00%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
+3.02%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
-1.24%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+4.20%
|
| Mar 21, 2025 Earnings Release 2025-03-21 (BEFORE OPEN) |
-7.88%
|
| Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE) |
+8.77%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.9%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)
📖 Intelligence Summary
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗